Muthi Ikawati

ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 8

Top Venues

Pharmacogenomics

Nutrition and cancer

Evidence-based complementary and alternative medicine : eCAM

Advanced pharmaceutical bulletin

Universitas Gadjah Mada

Nara Institute of Science and Technology (NAIST) (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Universitas Gadjah Mada Apr 01 2012

Indonesia

Associate Lecturer :: Faculty of Pharmacy, Department of Pharmaceutical Sciences

Nara Institute of Science and Technology (NAIST) May 16 2015 - Sep 30 2015

Japan

Appointed Special Research Assistant :: Graduate School of Biological Sciences, Laboratory of Gene Function in Animals

Universitas Gadjah Mada Jun 01 2008 - Mar 31 2012

Indonesia

Teaching Staff :: Faculty of Pharmacy, Department of Pharmaceutical Chemistry

Education History

Nara Institute of Science and Technology (NAIST) Apr 01 2012 - Sep 25 2018

Japan

PHD :: Gene Function in Animals

Publications

Adam Hermawan, Muthi Ikawati, Dyaningtyas Dewi Pamungkas Putri, Nurul Fatimah, Heri Himawan Prasetio
Nobiletin Inhibits Breast Cancer Stem Cell by Regulating the Cell Cycle: A Comprehensive Bioinformatics Analysis and In Vitro Experiments. Nutrition and cancer (2024)
Adam Hermawan, Muthi Ikawati, Dyaningtyas Dewi Pamungkas Putri, Nurul Fatimah, Heri Himawan Prasetio
Nobiletin Inhibits Breast Cancer Stem Cell by Regulating the Cell Cycle: A Comprehensive Bioinformatics Analysis and In Vitro Experiments. Nutrition and cancer 76 (7) (2024)
Hui Yin Yow, Muthi Ikawati, Soni Siswanto, Adam Hermawan, Alim Khodimul Rahmat, Janet Sui-Ling Tan, Ying Chew Tee, Kok-Peng Ng, Zullies Ikawati
Influence of genetic polymorphisms on pharmacokinetics and treatment response of mycophenolic acid: a scoping review. Pharmacogenomics 25 (5-6) (2024)
Hui Yin Yow, Muthi Ikawati, Soni Siswanto, Adam Hermawan, Alim Khodimul Rahmat, Janet Sui-Ling Tan, Ying Chew Tee, Kok-Peng Ng, Zullies Ikawati
Influence of genetic polymorphisms on pharmacokinetics and treatment response of mycophenolic acid: a scoping review. Pharmacogenomics (2024)
Hui Yin Yow, Muthi Ikawati, Soni Siswanto, Adam Hermawan, Alim Khodimul Rahmat, Janet Sui-Ling Tan, Ying Chew Tee, Kok-Peng Ng, Zullies Ikawati
Influence of genetic polymorphisms on pharmacokinetics and treatment response of mycophenolic acid: a scoping review. Pharmacogenomics 25 (5-6) (2024)
Skolastika Skolastika, Naufa Hanif, Muthi Ikawati, Adam Hermawan
Comprehensive Computational Analysis of Honokiol Targets for Cell Cycle Inhibition and Immunotherapy in Metastatic Breast Cancer Stem Cells. Evidence-based complementary and alternative medicine : eCAM 2022 (2022)
Adam Hermawan, Herwandhani Putri, Naufa Hanif, Muthi Ikawati
Integrative Bioinformatics Study of Tangeretin Potential Targets for Preventing Metastatic Breast Cancer. Evidence-based complementary and alternative medicine : eCAM 2021 (2021)
Edy Meiyanto, Herwandhani Putri, Yonika Arum Larasati, Rohmad Yudi Utomo, Riris Istighfari Istighfari Jenie, Muthi Ikawati, Beni Lestari, Noriko Yoneda-Kato, Ikuko Nakamae, Masashi Kawaichi, Jun-Ya Kato
Anti-proliferative and Anti-metastatic Potential of Curcumin Analogue, Pentagamavunon-1 (PGV-1), Toward Highly Metastatic Breast Cancer Cells in Correlation with ROS Generation. Advanced pharmaceutical bulletin 9 (3) (2019)

Muthi Ikawati.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Muthi Ikawati